Ledger.Open graph →
SEC Form D · filed July 26, 2019

Rainier Therapeutics, Inc

Offering
$19.2M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN LEANDRO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Justin Saliman · Los Angeles, CADirectorBrian L. Lee · New York, NYDirectorAmanda Hall · Calgary, Alberta, CanadaExec · DirectorBrothers L. Borowsky · New York, NYDirectorDavid Takes · Waverly, IADirectorDavid Willard · San Jose, CAExecGreg L. Borowsky · New York, NYExecMartin Gross · Boone, IADirectorShaun L. Borowsky · New York, NYDirectorReal Estate L. Global · Road Town,, British Virgin IslandsExecBrandon Mccarty · Durham, NCDirectorRobert Roy · Danvers, MADirectorWilliam J. Mulrow · Bethesda, MDDirectorDavid P. Paul · Bethesda, MDExecAlisa M. Mall · Bethesda, MDExecCharles E. Haldeman, Jr · Bethesda, MDDirectorKevin W. Reynolds · Bethesda, MDExec · DirectorW. M. Kelly · Bethesda, MDDirectorM. M. Banerjee · Bethesda, MDDirectorSteven A. Museles · Bethesda, MDExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗